Integra LifeSciences slides after lowering annual forecasts
IART•Integra LifeSciences lowered its FY2026 revenue outlook to $1.63 billion-$1.65 billion and adjusted EPS forecast to $2.30-$2.40. Shares fell 14.6% after the company cited flooding at its Cincinnati facility.
1. Forecasts lowered
Integra LifeSciences cut its FY2026 revenue outlook to $1.63 billion-$1.65 billion from $1.65 billion-$1.70 billion and its adjusted EPS forecast to $2.30-$2.40 from $2.40-$2.50. It also trimmed its Q3 revenue forecast to $410 million-$412 million from $410 million-$425 million.
2. Flooding disrupts output
The company said July flooding at its Cincinnati facility hurt Q3 revenue by about $7 million and expects a $15 million-$20 million impact on Q4 revenue. It expects full manufacturing to resume in Q227.
